Schatzman Randall C 5
5 · Bolt Biotherapeutics, Inc. · Filed Feb 7, 2023
Insider Transaction Report
Form 5
Schatzman Randall C
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2022-12-06$1.18/sh+2,500$2,954→ 7,859 total - Purchase
Common Stock
2022-06-06$1.64/sh+2,500$4,101→ 5,359 total
Footnotes (1)
- [F1]Shares acquired under the issuer's Employee Stock Purchase Plan.